RecruitingNCT05543447

DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device

DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device for Intracranial Aneurysms

Sponsor

Acandis GmbH

Enrollment

158 participants

Start Date

Dec 15, 2022

Study Type

OBSERVATIONAL

Conditions

Intracranial Aneurysm Flow Diverter

Summary

To analyse the clinical safety and efficacy of the DERIVO® 2heal® Embolisation Device in the standard clinical routine of flow diversion treatment with respect to the mid- and long-term clinical and angiographic outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Flow Diverter Treatment with DERIVO 2 Heal Embolisation Device for people with flow diverter and intracranial aneurysm. The study is currently recruiting participants at 17 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFlow Diverter Treatment with DERIVO 2 Heal Embolisation Device

Flow diversion therapy fpr intracranial aneurysm treatment.

Locations(17)

Universitätsklinikum Augsburg

Augsburg, Germany

Charité - Universitätsmedizin Berlin

Berlin, Germany

Klinikum Bremerhaven-Reinkenheide

Bremerhaven, Germany

Universitätsklinikum Köln

Cologne, Germany

Universitätsklinikum Carl Gustav Carus Dresden

Dresden, Germany

Universitätsklinikum Düsseldorf

Düsseldorf, Germany

Universitätsklinikum Essen

Essen, Germany

Krankenhaus Nordwest Frankfurt

Frankfurt am Main, Germany

Universitätsmedizin Halle

Halle, Germany

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

Westpfalz-Klinikum Kaiserslautern

Kaiserslautern, Germany

Universitätsklinikum Magdeburg

Magdeburg, Germany

Mühlenkreiskliniken | Johannes Wesling Klinikum Minden

Minden, Germany

Ludwig-Maximilians-Universität München

München, Germany

Technische Universität München

München, Germany

Klinikum Vest - Knappschaftskrankenhaus Recklinghausen

Recklinghausen, Germany

Städtisches Klinikum Solingen

Solingen, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05543447

Related Trials

Product Surveillance Registry

NCT01524276400 locations

Neurovascular Product Surveillance Registry

NCT0298812899 locations

A Multicenter Prospective Study of New Flow Diverter Stent on the Treatment of Intracranial Aneurysms in China

NCT07821957

A Study of Choydar Flow-Directed Mesh Stent in the Treatment of Unruptured Intracranial Aneurysms

NCT072283128 locations

General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Using Flow Diverter

NCT064166571 location